Home
Ra Capital Management, Director: ARS Pharmaceuticals SPRY Buy · Filed 24/03/27
Trade details
- Type
- Insider buy
- Amount
- $3,964,656
- Shares · price
- 437,600 sh · $9.06 a share
- Held after
- 8,994,374 sh
- Trade date
- 24/03/25
- Filed
- 24/03/27
- Days to filing
- 2 days
First buy since 2023
- Insiders buying this week
- 5 insiders
- Holding change
- +5.1%
ARS Pharmaceuticals trades, last 26 weeks
What else happened in ARS Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 24/02/24~24/04/24Ra Capital Management's recent trades
- Ra Capital Management
BuyArtiva Biotherapeutics
BuyArtiva Biotherapeutics
ARTV
$275.3K
31,000 sh
$275.3K
Filed 06/29
Traded 06/25
- Ra Capital Management
BuyArtiva Biotherapeutics
BuyArtiva Biotherapeutics
ARTV
$16.8K
1,876 sh
$16.8K
Filed 06/29
Traded 06/26
- Ra Capital Management
SellWerewolf Therapeutics
SellWerewolf Therapeutics
HOWL
$136.2K
389,216 sh
$136.2K
Filed 06/22
Traded 06/17
- Ra Capital Management
SellWerewolf Therapeutics
SellWerewolf Therapeutics
HOWL
$9,693
27,695 sh
$9,693
Filed 06/22
Traded 06/17
- Ra Capital Management
BuyHemab Therapeutics Holdings
BuyHemab Therapeutics Holdings
COAG
$1.5M
61,523 sh
$1.5M
Filed 06/17
Traded 06/16
